COLUMBUS, Ohio and FAYETTEVILLE, Ark., July 25, 2024 /PRNewswire/ — Paradigm and Highlands Oncology announce promising outcomes from their ongoing collaboration, demonstrating a forty five% enhance within the variety of sufferers enrolled in scientific trials. The achievement aligns with the aims to maximise the supply of scientific trials for all sufferers within the area.
Highlands is a big, neighborhood oncology most cancers heart positioned within the northwest Arkansas hall, which gives care not solely to Arkansas, however to surrounding Oklahoma and Missouri.
“Northwest Arkansas is a superb place to dwell, work and lift a household, nevertheless, there are great geographical limitations to participation in university-based scientific analysis packages within the area,” mentioned J. Thaddeus Beck, MD, FACP, Co-Founder and Medical Director of Analysis at Highlands Oncology. “Highlands is devoted to offering the very best high quality of most cancers care in addition to fulfilling the necessity for affected person entry to scientific trials in our neighborhood.”
“Entry to most cancers care varies dramatically relying on the place you reside,” mentioned Kent Thoelke, CEO, Paradigm. “We’re proud to assist create extra equitable entry to scientific trials for sufferers in Arkansas by way of our work with Highlands, in addition to in comparable communities throughout the US. We think about a world the place everybody can get essentially the most superior care attainable, irrespective of their geography.”
Highlands works with Paradigm to guage the feasibility of latest scientific trials and display screen sufferers for recruitment. This partnership has helped the analysis crew enhance productiveness and effectivity. First, Paradigm securely integrates affected person scientific knowledge from Highlands’ EMR, in addition to check outcomes from all 5 of Highlands’ molecular testing distributors to streamline all features of recruitment. Highlands additionally receives new part I, II, and III interventional therapeutic scientific trial alternatives by way of Paradigm from pharmaceutical and biotechnology sponsors which can be pre-qualified and aligned with Highlands’ native affected person inhabitants, capabilities, analysis portfolio, pursuits and aims.
“Highlands has elevated scientific trial affected person enrollment by 45% over the past two years, whereas additionally lowering the burden on the analysis division,” mentioned Adam Torres, BSBA, BSN, RN, CCRP, Director of Analysis Growth, Highlands Oncology. “These accomplishments have been achieved by way of the deployment of business main greatest practices, expertise, and automations, together with Paradigm, who has served as a useful associate for our analysis program.”
Learn extra particulars within the case research with Highlands Oncology.
About Highlands
Highlands Oncology gives complete most cancers care to Northwest Arkansas and the encircling areas. They deal with providing and offering entry to all of the sources you would possibly want when confronted with a most cancers analysis. Highlands prides itself on making world famend most cancers care obtainable to sufferers in Northwest Arkansas so they can obtain the care and remedy they want near those they love within the place they name dwelling.
About Paradigm
Paradigm is rebuilding the scientific analysis ecosystem by making a platform that allows equitable entry to trials for all sufferers, whereas enhancing trial effectivity and lowering the limitations to participation for healthcare suppliers. Incubated by ARCH Enterprise Companions and backed by main healthcare and life sciences buyers, Paradigm goals to interrupt down limitations throughout the trial ecosystem by way of one seamless infrastructure applied at healthcare supplier organizations, bringing doubtlessly life-saving therapies to sufferers sooner.
SOURCE Paradigm Well being, Inc.
